Adamis Pharmaceuticals Corp (NASDAQ:ADMP)

Delayed Data
As of 3:06pm ET
 -0.10 / -2.67%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Adamis Pharmaceuticals Corp have a median target of 6.25, with a high estimate of 6.40 and a low estimate of 5.00. The median estimate represents a +71.23% increase from the last price of 3.65.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Adamis Pharmaceuticals Corp. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 70.83%
Growthannually 37.41%


Growthquarterly 178.06%
Growthannually 205.28%
Key to the earnings and sales forecast charts.